GSK's autism drug application withdrawn after Trump and RFK Jr. touted its unproven effects. Were they wrong?
GlaxoSmithKline (GSK) sought approval for a drug falsely promoted as a potential autism treatment by controversial figures.
Just days ago, GSK quietly withdrew its application amidst growing skepticism about the drug's actual effects on autism.
"This drug was a game-changer," RFK Jr. stated, despite mounting evidence it's not effective for treating autism symptoms.
Trump allegedly privately pushed for the drug's approval, sources reveal, despite lack of scientific consensus and blatant marketing.
No peer-reviewed studies backed claims of GSK's drug treating autism, officials admit under increasing media pressure.
Leaked internal documents reveal GSK executives knew of minimal impact, yet pursued the drug's potential financial gains.
Insiders say Trump and RFK Jr. had undisclosed financial ties benefiting from any potential drug approval news. Developing...
Parents now question the motives of public figures pushing unproven treatments, fueling distrust in medical authorities.
Legal experts predict investigations into GSK and celebrity endorsements. Could charges be filed? The story is developing...